sponsored content
Rousselot and peptan build on innovation days success to boost customer-first strategy
30 Apr 2018
Son, Netherlands –
[17 April 2018] Leading producer of gelatin and collagen peptides, Rousselot,
started 2018 with a strong focus on innovation, in line with the company’s
global strategy. In March, alongside the launch of two new revolutionary
products – Peptan® IIm - hydrolyzed collagen type II matrix for
joint health and StabiCapsTM gelatins preventing crosslinking in
softgels, the company held the two-day event at its Expertise Center in Ghent
and laid the foundation stone for the new Rousselot Pilot Hall at the site.
With state-of-the-art R&D and Applications laboratories across the world
dedicated to scientific research, new product development and co-innovation,
Rousselot has committed to further strengthen this aspect of its service
offering, and to keep working closely with customers to support their growth
and formulation objectives.
2018 Innovation Days: a resounding success
The customer event,
hosting about 100 people, was developed around the theme: Innovation Days 2018, new perspectives in the pharma &
nutraceutical world. It provided customers with a unique perspective on the
product launches and allowed them to appreciate gelatin and collagen’s unique
potential for pioneering technologies in health care and medicine. Delegates
were also offered the opportunity to visit the laboratories and discuss
specific projects and opportunities with Rousselot and Peptan experts.
‘During these two
days, Rousselot and Peptan have clearly demonstrated how to give a tangible
dimension to innovation, not only by launching two new, innovative products,
but also by looking at the future of our business under a new light’, comments
Sandor Noordermeer, Vice-President Global Marketing & Sales.
‘The event represents
the realization of our efforts to position ourselves as a trusted partner that
not only provides high quality, safe ingredients, but that can also add value
in every phase of the innovation process. We are very excited to see the
results of our conversations and look forward to the next occasion’ adds
Noordermeer.
Building the future of innovation
In parallel to the
Innovation Days, Rousselot also announced the expansion of the Ghent site with
a new Pilot facility. The new building, scheduled for completion in early 2019,
will be fully dedicated to Rousselot’s and Peptan’s innovation pipeline. The
teams will be responsible for the testing, on an industrial scale, of the
progress and developments carried out at the Rousselot Expertise Center and the
Regional Application Laboratories. The new laboratory will ensure the
sustainability of the newly developed innovation concepts as well as accelerate
their adoption in the pharma, nutrition and food industry.
Jos Vervoort,
Executive Vice-President, Rousselot comments: The construction of this new
Rousselot Pilot Hall and the Innovation Days are only the first steps of our
improved commitment to bringing innovation closer to our customers, a top
priority within our business strategy. Sharing our knowledge and fostering the
discussion on key topics such as health care and medical science developments
is one of the ways we help them stay ahead of the market and achieve their
ambitions.
Rousselot and Peptan
experts will be available to discuss the latest innovations and specific
opportunities at Vitafoods 2018, stand H35.
